I. Juhan‐Vague

20.2k total citations · 2 hit papers
230 papers, 15.2k citations indexed

About

I. Juhan‐Vague is a scholar working on Hematology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, I. Juhan‐Vague has authored 230 papers receiving a total of 15.2k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Hematology, 73 papers in Cancer Research and 63 papers in Pulmonary and Respiratory Medicine. Recurrent topics in I. Juhan‐Vague's work include Blood Coagulation and Thrombosis Mechanisms (79 papers), Protease and Inhibitor Mechanisms (72 papers) and Blood properties and coagulation (61 papers). I. Juhan‐Vague is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (79 papers), Protease and Inhibitor Mechanisms (72 papers) and Blood properties and coagulation (61 papers). I. Juhan‐Vague collaborates with scholars based in France, Belgium and United Kingdom. I. Juhan‐Vague's co-authors include Marie‐Christine Alessi, Pierre‐Emmanuel Morange, P Vague, P Vague, Franck Peiretti, Paul Declerck, Gilles Nalbone, M.F. Aillaud, Désiré Collen and Jørgen Jespersen and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

I. Juhan‐Vague

228 papers receiving 14.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease

1997 524 citations Marie‐Christine Alessi, Franck Peiretti et al. profile →
Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay

1988 476 citations Marie‐Christine Alessi, I. Juhan‐Vague et al. profile →

Peers

Countries citing papers authored by I. Juhan‐Vague

Since Specialization

Citations

This map shows the geographic impact of I. Juhan‐Vague's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Juhan‐Vague with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Juhan‐Vague more than expected).

Fields of papers citing papers by I. Juhan‐Vague

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Juhan‐Vague. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Juhan‐Vague. The network helps show where I. Juhan‐Vague may publish in the future.

Co-authorship network of co-authors of I. Juhan‐Vague

This figure shows the co-authorship network connecting the top 25 collaborators of I. Juhan‐Vague. A scholar is included among the top collaborators of I. Juhan‐Vague based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Juhan‐Vague. I. Juhan‐Vague is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	p38 Mitogen Activated Protein Kinase Controls Two Successive-Steps During the Early Mesodermal Commitment of Embryonic Stem Cells 2010 ·Stem Cells and Development ·Emilie Barruet, Ola Hadadeh, Franck Peiretti, Valérie M. Renault, (unknown), Denis Bernot, Roselyne Tournaire, Didier Négre, I. Juhan‐Vague, Marie‐Christine Alessi, Bernard Binétruy	22
2	Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels 2010 ·Journal of Thrombosis and Haemostasis ·Géraldine Lavigne-Lissalde, Carlos Sánchez, Christel Castelli, Sandrine Alonso, E. Mazoyer, Claire Bal dit Sollier, Ludovic Drouet, I. Juhan‐Vague, Jean‐Christophe Gris, Marie‐Christine Alessi, Pierre‐Emmanuel Morange	21
3	Abstract 1026: Systemic Chemokines Levels and Incident Coronary Heart Disease and Ischemic Stroke Events in Asymptomatic Middle-aged Men: The Prime Study 2009 ·Circulation ·Florence Canouï‐Poitrine, (unknown), Gérald Luc, (unknown), Annie Bingham, Jean Ferrières, Jean‐Bernard Ruidavets, Michèle Montaye, John Yarnell, Bernadette Haas, Dominique Arveiler, Pierre‐Emmanuel Morange, I. Juhan‐Vague, Frank Kee, Alun Evans, Philippe Amouyel, Pierre Ducimetière, Jean‐Philippe Empana	1
4	Polymorphisms of the lamina maturation pathway and their association with the metabolic syndrome: the DESIR prospective study 2009 ·Journal of Molecular Medicine ·Bénédicte Fontaine‐Bisson, Marie‐Christine Alessi, Noémie Saut, Frédéric Fumeron, Michel Marre, Anne Dutour, Catherine Badens, Nicolas Lévy, Jean Tichet, I. Juhan‐Vague, David‐Alexandre Trégouët, B. Balkau, Pierre‐Emmanuel Morange	4
5	Metabolic syndrome, haemostasis and thrombosis 2008 ·Thrombosis and Haemostasis ·I. Juhan‐Vague, Marie‐Christine Alessi	136
6	Chronic plasminogen activator inhibitor‐1 (PAI‐1) overexpression dampens CD25+ lymphocyte recruitment after lipopolysaccharide endotoxemia in mouse lung 2007 ·Journal of Thrombosis and Haemostasis ·Marjorie Poggi, Odile Paulmyer‐Lacroix, Monique Verdier, Franck Peiretti, Delphine Bastelica, José Boucraut, H.R. Lijnen, I. Juhan‐Vague, Marie‐Christine Alessi	14
7	Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study 2007 ·Journal of Thrombosis and Haemostasis ·Pierre‐Emmanuel Morange, Stefan Blankenberg, Marie‐Christine Alessi, Christoph Bickel, H. J. Rupprecht, Renate B. Schnabel, Edith Lubos, Thomas Münzel, D Peetz, Viviane Nicaud, I. Juhan‐Vague, Laurence Tiret	56
8	TGF-β1 Released from Activated Platelets Can Induce TNF-Stimulated Human Brain Endothelium Apoptosis: A New Mechanism for Microvascular Lesion during Cerebral Malaria 2006 ·The Journal of Immunology ·Samuel C. Wassmer, J. Brian de Souza, Corinne Frère, Francisco J. Candal, I. Juhan‐Vague, Georges E. Grau	80
9	On the role of plasminogen activator inhibitor‐1 in adipose tissue development and insulin resistance in mice 2005 ·Journal of Thrombosis and Haemostasis ·H.R. Lijnen, Marie‐Christine Alessi, B. Van Hoef, D Collen, I. Juhan‐Vague	56
10	Plasma cystatin-C and development of coronary heart disease: The PRIME Study 2005 ·Atherosclerosis ·Gérald Luc, Jean‐Marie Bard, Céline Lesueur, Dominique Arveiler, Alun Evans, Philippe Amouyel, Jean Ferrières, I. Juhan‐Vague, Jean‐Charles Fruchart, Pierre Ducimetière	92
11	Substances produites par le tissu adipeux, obésité et risque vasculaire 2005 ·La Presse Médicale ·Marie‐Christine Alessi, Corinne Frère, I. Juhan‐Vague	1
12	Du fibrinogène à la fibrine et sa dissolution 2003 ·Bulletin de l Académie Nationale de Médecine ·I. Juhan‐Vague, (unknown)	1
13	A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease 2003 ·British Journal of Haematology ·Alain Stépanian, Anne‐Sophie Ribba, Jean‐Maurice Lavergne, Édith Fressinaud, I. Juhan‐Vague, Claudine Mazurier, Jean‐Pierre Girma, Dominique Meyer	15
14	Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study 2002 ·Atherosclerosis ·Pierre‐Yves Scarabin, Dominique Arveiler, Philippe Amouyel, (unknown), Alun Evans, Gérald Luc, Jean Ferrières, I. Juhan‐Vague	48
15	The insulin resistance syndrome: implications for thrombosis and cardiovascular disease 2002 ·Pathophysiology of Haemostasis and Thrombosis ·I. Juhan‐Vague, Pierre‐Emmanuel Morange, Marie‐Christine Alessi	58
16	Influence of PAI-1 on adipose tissue growth and on metabolic parameters in a murine model of diet-induced obesity 1999 ·Thrombosis and Haemostasis ·Pierre‐Emmanuel Morange, Roger Lijnen, Marie‐Christine Alessi, (unknown), Désiré Collen, I. Juhan‐Vague	2
17	Fibrinolytic function and coronary risk 1999 ·Current Cardiology Reports ·I. Juhan‐Vague, Pierre‐Emmanuel Morange, Marie‐Christine Alessi	27
18	TAFI : lien moléculaire entre les processus de coagulation et de fibrinolyse 1998 ·Sang thrombose vaisseaux ·I. Juhan‐Vague, Marie‐Christine Alessi	0
19	Fibrinogen, fibrinolysis and diabetes mellitus: a comment 1997 ·Diabetologia ·P Vague, I. Juhan‐Vague	21
20	Antiphospholipids in hemodialysis patients: Relationship between lupus anticoagulant and thrombosis 1995 ·Kidney International ·Philippe Brunet, (unknown), (unknown), (unknown), B. Dussol, Dominique Bernard, I. Juhan‐Vague, Yvon Berland	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact